Found "Health Promotion": 927 results
Sort by
Last updated

11th HTAsiaLink Annual Conference 2023 Awards Winners

The HTAsiaLink Annual Conference for this year happened on 4 – 7 September, hosted by the Malaysia Health Technology Assessment Section (MaHTAS) under the Ministry of Health, Malaysia. Researchers from HITAP participated in the conference and presented their research projects thr

10th HTAsiaLink Annual Conference 2022 Awards Winners

On 2 Dec 2022, our outstanding presenters received big achievements by winning amazing awards at the 10th HTAsiaLink Annual Conference 2022 which virtually held on 30 November – 2 December 2022. The winners are as listed below:Best Oral PresentationsTrack: Economic EvaluationSecond Prize: Chittawan

Preventing end-stage renal disease in Thai newly-diagnosed severe lupus nephritis patients: cost-effectiveness of alternative drug regimens (research for development of the health benefit package under the Universal Coverage scheme)

The purpose of this study is to compare the cost-utility of each treatment option available today in order to determine the most cost-effective treatment compared with standard treatment in the social perspective. Research methodology is an economic evaluation by using the markov model to compare the cost and utility of treatment options of new pat

Views of Health Professionals on Herbal Medicine and Policy for Promotion of Herbal Medicine Use in Healthcare Settings(in Thai Language)

Thailand has promoted the use of herbal medicine for many years, but the value of herbal medicine in public health facilities does not meet the established target. The survey of health practitioners towards herbal medicine and the policy in promotion of the use of herbal medicine in health practitioners gives us information reinforcing and resistan

Evaluation of the National Essential Drug List Category E2 2008 (in Thai language)

The objective of this study is to promote the rational drug use of Thailand. E List, clause 2 for specific patients is added in the National List of Essential Medicines, 2551 B.E. Ten medicines, which require knowledge, specialization in disease or advanced technology, are included in the list. However, it is likely that the prescription of these m

Effectiveness of home visit: A systematic review of systematic reviews

This study aims to explore effectiveness of home visit on clinical, economic, and humanistic outcomes employing systematic review. Home visits for all diseases and within all patient groups are included, provided that inclusion criteria are met. Results are expected to be useful for (1) developing guidelines for home visit for health professionals,

Cost-utility analysis of treatment for prevention of osteoporotic fractures

Background: Osteoporosis, a reduction in bone strength, is one of the most significant factors contributing to fractures, particularly in postmenopausal women. It affects not only patients’ life expectancy and quality of life, but also household expenditure on healthcare costs. Various screening methods to identify the risk of developing osteopo

Development and evaluation of communication interventions to prevent suicidal attempts (Phase II)

This is an intervention study research covers 18 districts in two provinces in the North of Thailand aiming at measuring effects of interventions. Three interventions are developed, namely (1) provision of supporting suicide prevention tools/guidelines for health volunteer and community leaders, (2) development of existing hotline and (3) use of co

Bird Flu Paper Is Published After Debate

The more controversial of two papers describing how the lethal H5N1 bird flu could be made easier to spread was published Thursday, six months after a scientific advisory board suggested that the papers’ most potentially dangerous data be censored.The paper, by scientists at Erasmus Medical Center i

Assessing the implications of Thailand’s government use licenses, issued in 2006-2008

This study aims to assess the impact of the compulsory licensing (CL ) policy issued by Thailand’s Ministry of Public Health during December 2006 to January 2008 on antiretroviral drugs - efavirenz and lopinavir/ritonavir combination, an oral antiplatelet agent - clopidogrel, and four anti-cancer drugs - imatinib, erlotinib, letrozole, and doceta
10 / Page